Press "Enter" to skip to content

New patent expiration for Pf Prism drug CHANTIX

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Pf Prism drug CHANTIX

Annual Drug Patent Expirations for CHANTIX
Annual Drug Patent Expirations for CHANTIX

Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from five suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

CHANTIX drug price trends.

Drug patent litigation for CHANTIX.

The generic ingredient in CHANTIX is varenicline tartrate. Five suppliers are listed for this compound. Additional details are available on the varenicline tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Pf Prism drug CHANTIX
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions